Scientists for the first time injected an AI-created virus into a human
Key Points:
- California-based AI startup Radical Numerics has administered an experimental treatment containing AI-designed bacteriophages to a human patient with a serious bacterial infection, marking the first known use of AI-designed viruses in human therapy.
- The AI model, Omnii-1, redesigns viruses to better recognize and attack specific bacterial strains, potentially speeding up the process of finding effective phage therapies from weeks or months to just days.
- The treatment was given under a special program for experimental therapies when conventional options are limited, but the company has not disclosed the patient’s diagnosis, treatment outcome, or whether the infection was cleared.
- Radical Numerics tested the AI-designed viruses against the patient’s antibiotic-resistant bacteria in the lab, where the virus mixture successfully eliminated the bacterial sample before administration.
- This development highlights growing interest in AI-driven medical research, while also raising biosafety concerns about the potential misuse of AI to design harmful viruses.